Identifying Novelties in COVID-19, Post-COVID ME/CFS Syndrome
Like many other countries, in the US autoimmune disorders affect up to 10% of the population. It has been shown that genes are responsible for only one-third of autoimmune disorders, and environmental factors are involved in the other two-thirds.
In this regard, Dr. Vojdani will share with the class his experiences about his participation in the 14th International Congress on Autoimmunity that occurred from May 17-20 in beautiful Ljubljana, Slovenia.
In this congress, the newest diagnostic tools and techniques as well as the most up-to-date research on the role of environmental triggers and novel therapies for autoimmune diseases were discussed by world-renowned scientists.
These are some of the highlights that will be presented to the class participants:
The importance of predictive and pathogenic antibodies in various autoimmune disorders
Increased intestinal permeability as an avenue for the development of autoimmune diseases
Mechanism of autoimmunity, and autoimmunity in the central nervous system due to breakdown in blood-brain barriers
Connection between adjuvants (silicone, aluminum, polyethylene glycol, mercury, tattoo, nanoparticles and other vaccine components) and hyperstimulation of the immune system that results in ASIA syndrome
The chemical and social landscape of the modern world and increased risk of autoimmunity
Nutrition and autoimmunity induction due to mimicry or cross-reactivity
Novelties in COVID-19, post-COVID syndrome, and autoimmunity with major emphasis on Dr. Vojdani’s presentations
The role of pathogens, particularly SARS-CoV-2, EBV and HHV-6 in long COVID and autoimmunity, with major emphasis on Dr. Vojdani’s presentation
Prediction, monitoring and prevention of autoimmunities
Novel autoimmune diseases, diagnosis and therapeutic challenges